Skip to main content

Basel Area has ever more to offer investors

| News

Basel Area has ever more to offer investors

28.01.2021

The canton of Basel-Stadt has displayed the most striking performance in the Swiss Venture Capital Report. Last year, more than 500 million Swiss francs were invested in startups in this canton.

Basel is an ideal place for business

Investment in Swiss startups totaled 2.1 billion francs in 2020, the latest Swiss Venture Capital Report has found. The Report is compiled by the news portal startupticker.ch in collaboration with the Swiss Private Equity & Corporate Finance Association (SECA). While this is a decline of 7.4 percent on the previous year, a press release highlights that for the first time since 2017, more money was invested in biotech than in ICT startups. As a result, Basel-Stadt was the big winner of the cantons.

Overall, startups in the canton received 540.4 million francs, which is more than a quarter of the total money invested and exceeds the previous record in 2018 fourfold. Since the first Swiss Venture Capital Report 2012, investment in startups from Basel-Stadt has increased by 403 percent. Of the 540.4 million francs, 530 million francs went to biotech companies, the biggest investment throughout Switzerland.

One company that contributed greatly was Versant Ventures. The international healthcare venture capital firm has just one of its biotech incubators in Europe – at the Technologiepark Basel. According to Alex Mayweg, Managing Director of Versant Ventures, the Basel Area border triangle is developing very rapidly from a classic pharma to a first-class biotech location at the moment.

Basel-Stadt also saw an increase in funds raised through financing rounds last year. With 29 rounds, Basel-Stadt has climbed the cantonal rankings from fifth place in 2019 to third in 2020. When it comes to total investment, Basel-Stadt has put an end to the dominance of the two sites of the Swiss Federal Institutes of Technology in Zurich and Vaud to take a clear second place behind Zurich.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Do you have a question? We'd like to hear from you.